Cargando…
In Search of Effective UiO-66 Metal–Organic Frameworks for Artificial Kidney Application
[Image: see text] The removal of uremic toxins from patients with acute kidney injury is a key issue in improving the quality of life for people requiring peritoneal dialysis. The currently utilized method for the removal of uremic toxins from the human organism is hemodialysis, performed on semiper...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485328/ https://www.ncbi.nlm.nih.gov/pubmed/34520182 http://dx.doi.org/10.1021/acsami.1c05972 |
_version_ | 1784577516004966400 |
---|---|
author | Dymek, Klaudia Kurowski, Grzegorz Kuterasiński, Łukasz Jędrzejczyk, Roman Szumera, Magdalena Sitarz, Maciej Pajdak, Anna Kurach, Łukasz Boguszewska-Czubara, Anna Jodłowski, Przemysław J. |
author_facet | Dymek, Klaudia Kurowski, Grzegorz Kuterasiński, Łukasz Jędrzejczyk, Roman Szumera, Magdalena Sitarz, Maciej Pajdak, Anna Kurach, Łukasz Boguszewska-Czubara, Anna Jodłowski, Przemysław J. |
author_sort | Dymek, Klaudia |
collection | PubMed |
description | [Image: see text] The removal of uremic toxins from patients with acute kidney injury is a key issue in improving the quality of life for people requiring peritoneal dialysis. The currently utilized method for the removal of uremic toxins from the human organism is hemodialysis, performed on semipermeable membranes where the uremic toxins, along with small molecules, are separated from proteins and blood cells. In this study, we describe a mixed-linker modulated synthesis of zirconium-based metal–organic frameworks for efficient removal of uremic toxins. We determined that the efficient adsorption of uremic toxins is achieved by optimizing the ratio between −amino functionalization of the UiO-66 structure with 75% of −NH(2) groups within organic linker structure. The maximum adsorption of hippuric acid and 3-indoloacetic acid was achieved by UiO-66-NH(2) (75%) and by UiO-66-NH(2) (75%) 12.5% HCl prepared by modulated synthesis. Furthermore, UiO-66-NH(2) (75%) almost completely adsorbs 3-indoloacetic acid bound to bovine serum albumin, which was used as a model protein to which uremic toxins bind in the human body. The high adsorption capacity was confirmed in recyclability test, which showed almost 80% removal of 3-indoloacetic acid after the third adsorption cycle. Furthermore, in vitro cytotoxicity tests as well as hemolytic activity assay have proven that the UiO-66-based materials can be considered as potentially safe for hemodialytic purposes in living organisms. |
format | Online Article Text |
id | pubmed-8485328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-84853282021-10-01 In Search of Effective UiO-66 Metal–Organic Frameworks for Artificial Kidney Application Dymek, Klaudia Kurowski, Grzegorz Kuterasiński, Łukasz Jędrzejczyk, Roman Szumera, Magdalena Sitarz, Maciej Pajdak, Anna Kurach, Łukasz Boguszewska-Czubara, Anna Jodłowski, Przemysław J. ACS Appl Mater Interfaces [Image: see text] The removal of uremic toxins from patients with acute kidney injury is a key issue in improving the quality of life for people requiring peritoneal dialysis. The currently utilized method for the removal of uremic toxins from the human organism is hemodialysis, performed on semipermeable membranes where the uremic toxins, along with small molecules, are separated from proteins and blood cells. In this study, we describe a mixed-linker modulated synthesis of zirconium-based metal–organic frameworks for efficient removal of uremic toxins. We determined that the efficient adsorption of uremic toxins is achieved by optimizing the ratio between −amino functionalization of the UiO-66 structure with 75% of −NH(2) groups within organic linker structure. The maximum adsorption of hippuric acid and 3-indoloacetic acid was achieved by UiO-66-NH(2) (75%) and by UiO-66-NH(2) (75%) 12.5% HCl prepared by modulated synthesis. Furthermore, UiO-66-NH(2) (75%) almost completely adsorbs 3-indoloacetic acid bound to bovine serum albumin, which was used as a model protein to which uremic toxins bind in the human body. The high adsorption capacity was confirmed in recyclability test, which showed almost 80% removal of 3-indoloacetic acid after the third adsorption cycle. Furthermore, in vitro cytotoxicity tests as well as hemolytic activity assay have proven that the UiO-66-based materials can be considered as potentially safe for hemodialytic purposes in living organisms. American Chemical Society 2021-09-14 2021-09-29 /pmc/articles/PMC8485328/ /pubmed/34520182 http://dx.doi.org/10.1021/acsami.1c05972 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Dymek, Klaudia Kurowski, Grzegorz Kuterasiński, Łukasz Jędrzejczyk, Roman Szumera, Magdalena Sitarz, Maciej Pajdak, Anna Kurach, Łukasz Boguszewska-Czubara, Anna Jodłowski, Przemysław J. In Search of Effective UiO-66 Metal–Organic Frameworks for Artificial Kidney Application |
title | In
Search of Effective UiO-66 Metal–Organic
Frameworks for Artificial Kidney Application |
title_full | In
Search of Effective UiO-66 Metal–Organic
Frameworks for Artificial Kidney Application |
title_fullStr | In
Search of Effective UiO-66 Metal–Organic
Frameworks for Artificial Kidney Application |
title_full_unstemmed | In
Search of Effective UiO-66 Metal–Organic
Frameworks for Artificial Kidney Application |
title_short | In
Search of Effective UiO-66 Metal–Organic
Frameworks for Artificial Kidney Application |
title_sort | in
search of effective uio-66 metal–organic
frameworks for artificial kidney application |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485328/ https://www.ncbi.nlm.nih.gov/pubmed/34520182 http://dx.doi.org/10.1021/acsami.1c05972 |
work_keys_str_mv | AT dymekklaudia insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT kurowskigrzegorz insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT kuterasinskiłukasz insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT jedrzejczykroman insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT szumeramagdalena insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT sitarzmaciej insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT pajdakanna insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT kurachłukasz insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT boguszewskaczubaraanna insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication AT jodłowskiprzemysławj insearchofeffectiveuio66metalorganicframeworksforartificialkidneyapplication |